Clearmind Medicine Inc. (CMND)
NCM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
April 2026
Executive order and bill boost Clearmind's psychedelic drug development
# 📰 What This Document Is This filing is an SEC Form 6-K, which is a type of filing used by foreign private issuers (like Clearmind Medicine) to announce material information to U.S. investors. Essentially, this document is a press release designed to inform the public and potential investors about
March 2026
Clearmind Medicine Inc. — 6-K Filing
# 🧾 What This Document Is This is a **6-K filing**, which is a report public foreign companies (like this Canadian one) file with the SEC to share important news. Think of it as a formal press release channel. This specific one announces a positive update from their ongoing clinical trial. 👉 **Th
SEC filings
All filings →Insider trades
All insider trades →Clearmind Medicine Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Clearmind Medicine Inc.
All people →No officers or directors have been indexed for Clearmind Medicine Inc..